Skip to main content
. Author manuscript; available in PMC: 2018 Apr 6.
Published in final edited form as: Support Care Cancer. 2017 Sep 15;26(2):605–613. doi: 10.1007/s00520-017-3874-6

Table 2.

Patient demographics and baseline geriatric assessment results

Patient Demographics
Control Intervention P Value
Gender Male – 54%
Female – 46%
Male – 59%
Female – 41%
0.66
Income Level ≤ 50K – 74%
> 50K – 26%
≤ 50K – 83%
> 50K – 17%
0.37
Insurance Coverage Medicare – 37%
Medicare + Medicaid – 3%
Medicare + Private – 43%
Medicare + Private – 17%
Medicare – 38%
Medicare + Medicaid – 5%
Medicare + Private – 41%
Medicare + Private – 16%
0.96
Race Caucasian – 97%
Other – 3%
Caucasian – 91%
Other – 9%
0.36
Education Level ≤ High School – 60%
> High School – 40%
≤ High School – 57%
> High School – 43%
0.96
Marital Status Married – 65%
Other – 35%
Married – 57%
Other – 43%
0.63
Tumor type GI – 38%
Lung – 47%
GU – 15%
Other – 0%
GI – 48%
Lung – 37%
GU – 8%
Other – 5%
0.16
Tumor Stage III – 32%
IV – 68%
III – 27%
IV – 72%
0.80
Line of therapy First – 94%
Second – 6%
First – 95%
Second -5%
1.00
Baseline Geriatric Assessment Results
Control Intervention P value
Activities of Daily Living (ADL) impairment 20% 27% 0.48
Instrumental Activities of Daily Living (IADL) impairment 31% 59% 0.02
3 Comorbidities 29% 41% 0.29
Physical Activity Impairment 60% 65% 0.67
Geriatric Depression Screen >5 12% 19% 0.52
Vision Impairment (self-report fair or worse) 14% 8% 0.47
Hearing Impairment (self-report fair or worse) 29% 19% 0.34
History of Falls 23% 27% 0.77
Self-rated Karnofsky Performance Status <70 14% 22% 0.32
Short Physical Performance Battery <9 69% 73% 0.68
Abnormal Mini-Cog score 19% 33% 0.12
Blessed Orientation-Memory-Concentration Test score >10 6% 3% 0.61
Baseline Cancer and Aging Research Group (CARG) Toxicity Score Low-9%
Medium-76%
High-15%
Low-19%
Medium-46%
High-35%
0.04